Stockscreener 앱 받기
43.58
0.57%
-0.25
Exelixis Inc 주식(EXEL)의 최신 뉴스
Aug Sectors: Is Exelixis Inc EX9 stock cheap vs fundamentalsEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Exelixis Announces Key Senior Leadership Hires in Medical Affairs, Sales, & Marketing to Support Commercialization of Cabozan... - ADVFN
See How Rare Bullish Inflows Lift Outliers Like Exelixis - Yahoo Finance
Here's Why Exelixis (EXEL) is a Strong Growth Stock - Yahoo Finance
Trading the Move, Not the Narrative: (EXEL) Edition - Stock Traders Daily
EXELExelixis Announces Second Quarter 2013 Financial Results - ADVFN
Does Exelixis (NASDAQ:EXEL) Deserve A Spot On Your Watchlist? - Yahoo Finance
Exelixis Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients with Hepatocellular Carcinoma - ADVFN
Exelixis Announces Initiation of Investigator-Sponsored Clinical Trial Combining Cabozantinib & Abiraterone in Men With Castr... - ADVFN
Exelixis Announces Positive Overall Survival Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafeni... - ADVFN
Exelixis Inc Stock Analysis and ForecastLarge Cap Stability Picks & Double Or Triple Capital - earlytimes.in
Exelixis Announces Presentation of Updated Phase 1b Results for the Combination of Cobimetinib & Atezolizumab in Metastatic C... - ADVFN
Exelixis Announces Results from a Phase 2 Investigator-Sponsored Trial of Cabozantinib in the First-Line Treatment of Metasta... - ADVFN
Exelixis Receives $150 Million Funding Commitment From Deerfield Management - ADVFN
Exelixis Expands the Cabozantinib Development Program Through NCI-CTEP Collaboration - ADVFN
Exelixis Announces Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refract... - ADVFN
Exelixis Earnings Notes - Trefis
History Review: Is Exelixis Inc stock trading at a premium valuationPortfolio Return Summary & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
Exelixis (MIC:EXEL-RM) EV-to-FCF : 0.00 (As of Dec. 26, 2025) - GuruFocus
Exelixis (HAM:EX9) EV-to-OCF : 13.21 (As of Dec. 22, 2025) - GuruFocus
Why Exelixis, Inc. (EXEL) Skyrocketed On Wednesday - MSN
Published on: 2025-12-21 13:28:36 - Улправда
How Exelixis Inc. stock reacts to job market dataMarket Risk Report & Safe Swing Trade Setups - ulpravda.ru
Behavioral Patterns of EXEL and Institutional Flows - news.stocktradersdaily.com
Published on: 2025-12-20 10:46:18 - Улправда
Can Exelixis Inc. stock hit analyst price targetsJuly 2025 Levels & Growth Focused Stock Reports - Улправда
Exelixis and Merck Advance LITESPARK-033: A New Kidney Cancer Combo With High-Stakes Market Potential - TipRanks
Exelixis (FRA:EX9) EV-to-OCF : 12.63 (As of Dec. 19, 2025) - GuruFocus
Will Exelixis Inc. stock benefit from infrastructure spendingJuly 2025 Sector Moves & AI Based Trade Execution Alerts - DonanımHaber
Gap Down: Can Exelixis Inc. (EX9) stock stage a strong rebound this quarterPortfolio Value Report & Short-Term Swing Trade Alerts - DonanımHaber
Is Exelixis Inc. stock a defensive play in 2025July 2025 Levels & Real-Time Market Trend Scan - DonanımHaber
Rally Mode: How analysts revise price targets for Exelixis Inc. (EX9) stock2025 Biggest Moves & Precise Buy Zone Tips - Улправда
Stelios Papadopoulos brings the long view on biotech on The BioCentury Show - biocentury.com
Returns Recap: How Exelixis Inc EX9 stock compares with top peersQuarterly Profit Report & Real-Time Buy Zone Alerts - moha.gov.vn
Why Exelixis Inc. (EX9) stock stays on buy listsWeekly Profit Analysis & Verified Stock Trade Ideas - ulpravda.ru
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term - Yahoo Finance
Citizens reiterates Market Outperform rating on Exelixis stock at $50 By Investing.com - Investing.com Canada
Exelixis, Inc.Common Stock (NQ: EXEL - FinancialContent
Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Owlet (OWLT), Exelixis (EXEL) - The Globe and Mail
VP Haley Files To Sell 23,539 Of Exelixis Inc [EXEL] - TradingView — Track All Markets
Exelixis Inc (HAM:EX9)Valuation Measures & Financial Statistics - GuruFocus
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Exelixis (EXEL) and Natera (NTRA) - theglobeandmail.com
Exelixis Inc (HAM:EX9) Dividend - GuruFocus
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era - The Manila Times
Exelixis (EXEL) Receives a Hold from RBC Capital - theglobeandmail.com
Exelixis stock holds steady as Stifel maintains $43 price target By Investing.com - Investing.com Canada
Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D DaySlideshow (NASDAQ:EXEL) 2025-12-11 - Seeking Alpha
EXEL to Host Research and Development Day in December - GuruFocus
Analyst Upgrade: Can Exelixis Inc EX9 stock stage a strong rebound this quarterSell Signal & Daily Profit Focused Stock Screening - moha.gov.vn
(EXEL) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
It's A Story Of Risk Vs Reward With Exelixis, Inc. (NASDAQ:EXEL) - 富途牛牛
Exelixis (EX9.DE) Stock Analysis: Navigating Challenges with Resilience - Meyka
Earnings Recap: Can Exelixis Inc stock hit analyst price targetsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - moha.gov.vn
Exelixis (EXEL) Surpasses Q1 Earnings and Revenue Estimates - sharewise.com
Exelixis Stock Presents a Complex Investment Narrative - AD HOC NEWS
Levels Update: How analysts revise price targets for Exelixis Inc EX9 stockJuly 2025 Movers & Verified Momentum Stock Ideas - moha.gov.vn
Exelixis shuttering Pennsylvania site, laying off 130 employees - MSN
0.57%
자본화:
|
볼륨(24시간):